Pancreatic secretory trypsin inhibitor in cancer.
1988
M Ogawa, and
N Tomita, and
A Horii, and
N Matsuura, and
M Higashiyama, and
T Yamamoto, and
A Murata, and
T Mori, and
K Matsubara
Second Department of Surgery, Osaka University Medical School, Japan.
UI
MeSH Term
Description
Entries
D009369
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D006801
Humans
Members of the species Homo sapiens.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014361
Trypsin Inhibitors
Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds.